Recent Publications
Click My NCBI for full Bibliography
Steering research on mRNA splicing in cancer towards clinical translation
O.Anczukow, F.H.T.Allain, B.L.Angarola, D.L.Black, A.N.Brooks, C.Cheng, A.Conesa, E.I.Crosse, E.Eyras, E.Guccione, S.X.Lu, K.M.Neugebauer, P.Sehgal, X.Song, Z.Tothova, J.Valcárcel, K.M.Weeks, G.W.Yeo, and A.Thomas-Tikhonenko, Nat Rev Cancer, doi: 10.1038/s41568-024-00750-2, 2024
Contrasting and combining transcriptome complexity captured by short and long RNA sequencing reads
S.W. Han, S.Jewell, A.Thomas-Tikhonenko, and Y.Barash, Genome Res, 34(10):1624-1635, 2024
An Alternatively Spliced Gain-of-Function NT5C2 Isoform Contributes to Chemoresistance in Acute Lymphoblastic Leukemia
M.Torres-Diz, C.Reglero, C.D.Falkenstein, A.Castro, K.E.Hayer, C.M.Radens, M.Quesnel-Vallières, Z.Ang, P.Sehgal, M.M.Li, Y.Barash, S.K.Tasian, A.Ferrando, and A.Thomas-Tikhonenko, Cancer Res, 84(20):3327–3336, 2024
Lymphoma immunotherapy: the garden of forking paths
Z.Ang and A.Thomas-Tikhonenko, Blood, 143(8):655–657, 2024
MAJIQlopedia: an encyclopedia of RNA splicing variations in human tissues and cancer
M.Quesnel-Vallières, S.Jewell, K.W.Lynch, A.Thomas-Tikhonenko, and Y.Barash, Nucleic Acids Res, 52(D1):D213-D221, 2024
Alternative splicing of its 5’ untranslated region controls CD20 mRNA translation and enables resistance to CD20-directed immunotherapies
Z.Ang, L.Paruzzo, K.E.Hayer, C.Schmidt, M.Torres-Diz, S.Zheng, F.Xu, U.Zankharia, Y.Zhang, S.S.Soldan, S.Zheng, C.D.Falkenstein, J.P.Loftus, S.Y.Yang, M.Asnani, P.King Sainos, V.Pillai, E.Chong, M.M.Li, S.K.Tasian, Y.Barash, P.M.Lieberman, M.Ruella,S.J.Schuster, and A.Thomas-Tikhonenko, Blood, 142(20):1724-1739, 2023
Mapping and modeling human colorectal carcinoma interactions with the tumor microenvironment
N.Li, Q.Zhu, Y.Tian, K.J.Ahn, X.Wang, Z.Cramer, I.W.Folkert, P.Yu, J.Jou, S.Adams-Tzivelekidis, P.Sehgal, N.N.Mahmoud, C.B.Aarons, R.E.Roses, A.Thomas-Tikhonenko, E.E.Furth, B.Z.Stanger, A.Rustgi, M.Haldar, B.W.Katona, K.Tan, and C.J.Lengner, Nat Commun, 14(120):7915, 2023
FBXW7ß isoform drives transcriptional activation of the proinflammatory TNF cluster in human pro-B cells
S.Y.Yang, K.E.Hayer, H.Fazelinia, L.A.Spruce, M.Asnani, K.L.Black, A.S.Naqvi, V.Pillai, Y.Barash, K.S.J.Elenitoba-Johnson, and A.Thomas-Tikhonenko, Blood Adv, 7(7):1077-1091, 2023
Discovery of antibodies targeting multipass transmembrane proteins using a suspension cell-based evolutionary approach
P.J.Krohl, J.Fine, H.Yang, D.VanDyke, Z.Ang, K.B.Kim, A.Thomas-Tikhonenko, and J.B.Spangler, Cell Rep Methods, 3(3):100429, 2023
A Bayesian model for unsupervised detection of RNA splicing based subtypes in cancers
D.Wang, M.Quesnel-Vallieres, S.Jewell, M.Elzubeir, K.Lynch, A.Thomas-Tikhonenko, and Y.Barash, Nat Commun 14(1):63, 2023
A convergent malignant phenotype in B-cell acute lymphoblastic leukemia involving the splicing factor SRRM1
A.Closa, M.Reixachs-Sole, A.C.Fuentes-Fayos, K.E.Hayer, J.L.Melero, F.R.S.Adriaanse, R.S.Bos, M.Torres-Diz, S.P.Hunger, K.G.Roberts, C.Mullighan, R.W.Stam, A.Thomas-Tikhonenko, J.P.Castano, R.M.Luque, and E.Eyras, NAR Cancer 4(4):zcac041, 2022
High-throughput mutagenesis identifies mutations and RNA-binding proteins controlling CD19 splicing and CART-19 therapy resistance
M.Cortés-López, L.Schulz, M.Enculescu, C.Paret, B.Spiekermann, M.Quesnel-Vallières, M.Torres-Diz, S.Unic, A.Busch, A.Orekhova, M Kuban, M.Mesitov, M.Mulorz, R.Shraim, F.Kielisch, J.Faber, Y.Barash, A.Thomas-Tikhonenko, K.Zarnack, S.Legewie, and J.König, Nat Commun 13(1):5570, 2022
Loss of AID exacerbates the malignant progression of CLL
A.C.Lee, S.R.Pingali, J.A.Pinilla-Ibarz, M.L.Atchison, C.Koumenis, Y.Argon, A.Thomas-Tikhonenko, C.De Trez, C.A.Hu, and C.A.Tang, Leukemia 36(10):2430–2442, 2022
Identifying common transcriptome signatures of cancer by interpreting deep learning modelsA.Jha, M.Quesnel-Vallières, D.Wang, A.Thomas-Tikhonenko, K.W.Lynch, and Y.Barash, Genome Biol 23(1):117, 2022
Targeting CD123 in blastic plasmacytoid dendritic cell neoplasm using allogeneic anti-CD123 CAR T cells
T.Cai, A.Gouble, K.L.Black, A.S.Naqvi, D.Taylor, M.Zhao, Q.Yuan, M.Sugita, R.Galetto, S.Filipe, A.Cavazos, L.Han, Q.Zhang, V.Kuruvilla, H.Ma, C.G.Liu, X.Liu, S.Konoplev, J.Gu, G.Tang, X.Su, G.Al-Atrash, S.Ciurea, S.S.Neelapu, A.A.Lane, H.Kantarjian, M.L.Guzman, N.Pemmaraju, J.Smith, A.Thomas-Tikhonenko, and M.Konopleva, Nat Commun 13(1):2228, 2022
Modulation of CD22 protein expression in childhood leukemia by pervasive splicing aberrations: implications for CD22-directed immunotherapy
S.Zheng, E.Gillespie, Ammar S. Naqvi, K.E.Hayer, Z.Ang, M.Torres-Diz, M.Quesnel-Vallières, D.A.Hottman, A.Bagashev, J.Chukinas, C.Schmidt, M.Asnani, R.Shraim, D.M.Taylor, S.R.Rheingold, M.M.O’Brien, N.Singh, K.W.Lynch, M.Ruella, Y.Barash, S.K.Tasian, and A.Thomas-Tikhonenko, Blood Cancer Discov 3(2):103–115, 2022
MYC hyperactivates WNT signaling in APC/CTNNB1-mutated colorectal cancer cells through miR-92a-dependent repression of DKK3
P.Sehgal, C.Lanauze, X.Wang, K.E.Hayer, M.Torres-Diz, N.A.Leu, Y.Sela, B.Z.Stanger, C.J. Lengner, and A.Thomas-Tikhonenko, Mol Cancer Res 19(12):2003-2014, 2021
Tilting MYC toward cancer cell death
C.T.Harrington, E.Sotillo, C.V.Dang, and A.Thomas-Tikhonenko, Trends Cancer 7(11):982-994, 2021
RNA-binding proteins of COSMIC significance in cancer
P.S.Choi and A.Thomas-Tikhonenko, J Clin Invest 131(18):e151627, 2021
Direct long-read RNA sequencing identifies a subset of questionable exitrons likely arising from reverse transcription artifacts
L.Schulz, M.Torres-Diz, M.Cortés-López, K.E.Hayer, M.Asnani, S.K.Tasian, Y.Barash, E.Sotillo, K.Zarnack, J.König, and A.Thomas-Tikhonenko, Genome Biol 22(1):190, 2021
MOCCASIN: A method for correcting for known and unknown confounders in RNA splicing analysis
B.Slaff, C.M.Radens, P.Jewell, A.Jha, N.F.Lahens, G.R.Grant, A.Thomas-Tikhonenko, K.W.Lynch, and Y.Barash, Nat Commun 12(1):3353, 2021
Colorectal cancer-associated Smad4 R361 hotspot mutations boost Wnt/β-catenin signaling through enhanced Smad4-LEF1 binding
C.B.Lanauze, P.Sehgal, K.Hayer, M.Torres-Diz, J.A.Pippin, S.F.A.Grant, and A.Thomas-Tikhonenko, Mol Cancer Res 19(5):823-833, 2021
IFITM3 functions as a PIP3 scaffold to amplify PI3K signalling in B cells
J.Lee, M.E.Robinson, N.Ma, D.Artadji, M.A.Ahmed, G.Xiao, T.Sadras, G.Deb, J.Winchester, K.N.Cosgun, H.Geng, L.N.Chan, K.Kume, T.P.Miettinen, Y.Zhang, M.A.Nix, L.Klemm, C.W.Chen, J.Chen, V.Khairnar, A.P.Wiita, A.Thomas-Tikhonenko, M.Farzan, J.U.Jung, D.M.Weinstock, S.R.Manalis, M.S.Diamond, N.Vaidehi, and M.Müschen, Nature 588(4):491–497, 2020
Retention of CD19 intron 2 contributes to CART-19 resistance in leukemias with subclonal frameshift mutations in CD19
M.Asnani, K.E.Hayer, A.S.Naqvi, S.Zheng, S.Y.Yang, D.Oldridge, F.Ibrahim, M.Maragkakis, M.R.Gazzara, K.L.Black, A.Bagashev, D.Taylor, Z.Mourelatos, S.A.Grupp, D.Barrett, J.M.Maris, E.Sotillo, Y.Barash, and A.Thomas-Tikhonenko, Leukemia 34(4):1202–1207, 2020